1491
Fatal agranulocytosis in an Indian male receiving 100mg of dapsone daily, hospitalized for mid-borderline leprosy in type I reaction with triple nerve paralysis is reported.
 mid-borderline leprosy in type I reaction with triple nerve paralysis: Subject; Indian: Subject.Race; male: Subject.Gender; Fatal agranulocytosis: Effect; 100mg of dapsone daily: Treatment; 100mg: Treatment.Dosage; dapsone: Treatment.Drug; daily: Treatment.Freq; mid-borderline leprosy in type I reaction with triple nerve paralysis: Treatment.Disorder
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 mid-borderline leprosy in type I reaction with triple nerve paralysis: Subject; Indian: Subject.Race; male: Subject.Gender; Fatal agranulocytosis: Effect; 100mg of dapsone daily: Treatment; 100mg: Treatment.Dosage; dapsone: Treatment.Drug; daily: Treatment.Freq; mid-borderline leprosy in type I reaction with triple nerve paralysis: Treatment.Disorder